Dietmar Dammerer: How Should We Manage Traumatic Brain Injury When on Anticoagulants?
Dietmar Dammerer, Head of the Department of Orthopedics and Traumatology at the University Hospital Krems, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Archives of Orthopaedic and Trauma Surgery, adding:
”NEW PUBLICATION.
How should we manage patients with mild traumatic brain injury who are taking anticoagulants?
Despite the growing number of patients on antithrombotic therapy presenting to emergency departments after head trauma, clinical practice remains far from uniform.
I’m excited to share our newly published nationwide survey examining how Austrian trauma and neurosurgical departments manage patients with mild traumatic brain injury (mTBI) receiving antiplatelet agents, vitamin K antagonists, or direct oral anticoagulants.
Key findings:
- Nearly all participating departments routinely perform cranial CT scans in anticoagulated patients after mild head injury.
- Significant regional differences exist regarding hospital admission practices, particularly for patients receiving DOACs and those with hemophilia.
- Management strategies vary considerably across Austria, highlighting the absence of up-to-date national guidance.
As healthcare systems face increasing patient volumes and resource constraints, standardized, evidence-based protocols are becoming more important than ever.
Our findings underline a clear opportunity: developing contemporary national guidelines that support both patient safety and efficient resource utilization.
A sincere thank you to all participating departments and colleagues who contributed to this nationwide effort.
The full publication is now available, and I look forward to discussing its implications for trauma care, emergency medicine, neurosurgery, and healthcare policy.”
Title: Regional differences in the management of patients with mild traumatic brain injury and antithrombotic therapy—an Austrian survey
Authors: Barbara Sebek, Dietmar Dammerer, David Putzer, Lukas Moser
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion